Prelude Capital Management’s Ambit Biosciences Corp AMBI Stock Holding History

Prelude Capital Management’s Portfolio AMBI Stock Details AMBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-5,000	Closed	-$77K	–	2419
2014 Q3	$77K	Buy	+5,000	New	+$34.4K	0.01%	1219
2014 Q2	–	Sell	-3,700	Closed	-$34K	–	2424
2014 Q1	$34K	Buy	+3,700	New	+$39.3K	﹤0.01%	1538

Prelude Capital Management's AMBI Position: Q4 2014 in Review

Prelude Capital Management sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 5,000 shares — an estimated $77K sold.

Prelude Capital Management first reported a position in AMBI in Q1 2014 and held it in 2 quarters. The position peaked at $77K in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

Prelude Capital Management reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
Prelude Capital Management sold 5,000 Ambit Biosciences Corp shares in Q4 2014, an estimated $77K.
Prelude Capital Management first reported a position in Ambit Biosciences Corp in Q1 2014 and held it in 2 quarters.
Prelude Capital Management's Ambit Biosciences Corp position peaked at $77K in Q3 2014.
0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on Prelude Capital Management's 13F filing for Q4 2014, filed 13 Feb 2015.